AGENUS INC — Investor Relations & Filings
Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| 10-Q - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | |
| 8-K - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | |
| DEF 14A - AGENUS INC (0001098972) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - AGENUS INC (0001098972) (Subject) | 2026-03-26 | English | |
| 8-K - AGENUS INC (0001098972) (Filer) | 2026-03-26 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46361646 | 8-K | 2026-05-15 | English | ||
| 45001328 | 10-Q - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | ||
| 44960365 | 8-K - AGENUS INC (0001098972) (Filer) | 2026-05-11 | English | ||
| 39218368 | DEF 14A - AGENUS INC (0001098972) (Filer) | 2026-04-30 | English | ||
| 33051679 | SCHEDULE 13G/A - AGENUS INC (0001098972) (Subject) | 2026-03-26 | English | ||
| 33048504 | 8-K - AGENUS INC (0001098972) (Filer) | 2026-03-26 | English | ||
| 32887479 | 4 - AGENUS INC (0001098972) (Filer) | 2026-02-24 | English | ||
| 27360653 | 4 Filing | 2026-02-09 | English | ||
| 27360005 | 4 Filing | 2026-01-26 | English | ||
| 27360607 | SCHEDULE 13D Filing | 2026-01-23 | English | ||
| 27360811 | 8-K Filing | 2026-01-16 | English | ||
| 27360755 | 3 Filing | 2026-01-16 | English | ||
| 27359870 | 8-K Filing | 2026-01-14 | English | ||
| 27360545 | 4 Filing | 2026-01-12 | English | ||
| 27359929 | 8-K Filing | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
AGENUS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34023/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34023 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34023 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34023 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34023}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AGENUS INC (id: 34023)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.